Scholars Central

Conference abstractPublished 2020

Serum Tryptase as a marker of total Basophil compartment in Chronic Myeloid Leukemia (CML)-CP

Authors: Manisha Naithani

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Basophilia has always been a marker of blast burden and treatment monitoring in Chronic Myeloid Leukemia. However, due to possible misidentification and counting, overall all basophil burden can be wrong and hamper with treatment monitoring. Thus, there is a need for a biomarker which can be a good representative of basophil compartment in CML. Methodology: 40 newly diagnosed CML patients were selected from Medical oncology Hematology OPD of AIIMS, Rishikesh based on their baseline BCR-ABL status. Baseline basophil count was calculated and Tryptase levels were measured on all patients and statistical analysis was done using SPSS software. Results: Peripheral baseline basophil levels showed a significant correlation with baseline tryptase levels (p<0.01) and tryptase also correlate with EUTOS score, which has basophil count as one of its important parameters. This may signify that tryptase levels can be a marker of basophil count in CML.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Research & Reviews: Drug Delivery.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalResearch & Reviews: Drug Delivery
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Manisha Naithani”